Last month, ICICIDirect Research initiated coverage on Mazagaon Dock with a buy rating and a target price of Rs 560, whereas Equirus sees Ceat at Rs 3,654 in next three years on the back of rising market shares of the tyre company.
Moderna shares soar 135% in a day after cancer vaccine succeeds in late-stage trial
Moderna shares surged after its personalized mRNA cancer vaccine trial showed positive results. The treatment, combined with Keytruda, reduced melanoma recurrence and spread significantly. This